Update on the management of Duchenne muscular dystrophy

Update on the management of Duchenne muscular dystrophy

Manzur AY; Kinali M; Muntoni F

Archives Of Disease In Childhood

2008

Humans; Male; patient care team; Cardiomyopathy; Muscular Dystrophy; Physical Therapy Modalities; Respiration Disorders/etiology/therapy; Dilated/etiology/therapy; Duchenne/complications/diagnosis/genetics/therapy; Dystrophin/genetics; Gene Therapy/methods; Glucocorticoids/therapeutic use; Scoliosis/etiology/therapy

Duchenne muscular dystrophy (DMD) is familiar to paediatricians as the most common childhood muscular dystrophy and leads to severe disability and early death in the late teenage years if untreated. Improvements in general care, glucocorticoid corticosteroid treatment, non-invasive ventilatory support, and cardiomyopathy and scoliosis management have significantly changed the course of DMD in treated individuals, so that survival into adulthood is now a realistic possibility for most patients. This has important implications for the medical and social sectors involved in the transition to adult medical services and the provision of suitable employment and social care. Multidisciplinary team working for optimal management of DMD-specific multisystem complications is essential, and collaboration in disease specific national clinical networks is recommended. Several curative therapeutic strategies including cell and gene therapy are being pursued but are still at an experimental stage.

2008

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Journal Article

Backlog